These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36346458)

  • 1. Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs).
    Pisacane A; Cascardi E; Berrino E; Polidori A; Sarotto I; Casorzo L; Panero M; Boccaccio C; Verginelli F; Benvenuti S; Dellino M; Comoglio P; Montemurro F; Geuna E; Marchiò C; Sapino A
    Virchows Arch; 2023 Mar; 482(3):463-475. PubMed ID: 36346458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of metastatic neoplasms with unknown primary.
    Bochtler T; Löffler H; Krämer A
    Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratins and lung carcinomas.
    Nhung NV; Mirejovský P; Mirejovský T; Melínová L
    Cesk Patol; 1999 Jul; 35(3):80-4. PubMed ID: 11038661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
    Alberti C
    G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
    Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
    Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis.
    Tot T; Samii S
    APMIS; 2003 Dec; 111(12):1075-82. PubMed ID: 14678015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
    Tot T
    Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry, carcinomas of unknown primary, and incidence rates.
    Stelow EB; Yaziji H
    Semin Diagn Pathol; 2018 Mar; 35(2):143-152. PubMed ID: 29224972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.
    Tot T
    Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.
    Park SY; Kim BH; Kim JH; Lee S; Kang GH
    Arch Pathol Lab Med; 2007 Oct; 131(10):1561-7. PubMed ID: 17922593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases.
    Tot T
    Ann Diagn Pathol; 1999 Dec; 3(6):350-6. PubMed ID: 10594286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CUP syndrome: are there advances?].
    Moll R
    Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma.
    Tot T
    Eur J Cancer; 2002 Apr; 38(6):758-63. PubMed ID: 11937308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract.
    Tot T
    APMIS; 2000 Jun; 108(6):467-72. PubMed ID: 11028811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKX3.1 as a marker of prostatic origin in metastatic tumors.
    Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM
    Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R; Haltas H; Yenidunya S
    Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
    Srodon M; Westra WH
    Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The limited difference between keratin patterns of squamous cell carcinomas and adenocarcinomas is explicable by both cell lineage and state of differentiation of tumour cells.
    van Dorst EB; van Muijen GN; Litvinov SV; Fleuren GJ
    J Clin Pathol; 1998 Sep; 51(9):679-84. PubMed ID: 9930073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.